Treatment of cancer patients with autologous lymphocytes pre-incubated with T.F. from long survivors.
Fazio
M
M
Cattedra di Oncologia Medica dell'Università di Torino.
Negri
L
L
Mastromatteo
V
V
Pacchioni
D
D
Calabrese
F
F
Giacomasso
S
S
D000230:Adenocarcinoma / Q000276:immunology / Q000556:secondary / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000628:therapy*; D003110:Colonic Neoplasms / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D007962:Leukocytes / Q000276:immunology; D008175:Lung Neoplasms / Q000276:immunology / Q000556:secondary / Q000628:therapy*; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D012397:Rosette Formation; D014165:Transfer Factor / Q000627:therapeutic use*
D014165:Transfer Factor